Acetamide, 2-amino-N-[5-[6-chloro-5-[[[4-(1,1-dimethylethyl)phenyl]sulfonyl]amino]-3-pyridinyl]-4-methyl-2-thiazolyl]-

PI3KD/V-IN-01 is a highly potent ATP-competitive PI3Kδ/Vps34 dual inhibitor. In cells, PI3KD/V-IN-01 showed 30-300 fold selectivity between PI3Kδ and other class I PI3K isoforms. PI3KD/V-IN-01 exhibited better anti-proliferative activity against AML, CLL and Burkitt lymphoma cell lines than known selective PI3Kδ and Vps34 inhibitors.

PI3K-IN-12 (comp 76) is a PI3K inhibitor[1].

[1] NEW PI3K KINASE INHBITORS. Patent. WO2016101553A1.